IDEAYA Biosciences, Inc.
IDYA
$33.09
$0.260.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -169.83% | 253.88% | -7.36% | 44.61% | -151.47% |
| Total Depreciation and Amortization | 16.21% | -16.46% | 8.83% | 76.21% | -36.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.33% | 11.54% | 42.07% | 41.37% | 18.61% |
| Change in Net Operating Assets | -259.67% | 154.01% | 8.58% | 23.19% | 251.30% |
| Cash from Operations | -163.63% | 327.64% | -3.53% | 50.40% | -147.10% |
| Capital Expenditure | -692.86% | 93.67% | 50.15% | -20.69% | -141.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -332.47% | -10.24% | -42.60% | 141.40% | -901.11% |
| Cash from Investing | -333.50% | -9.04% | -42.47% | 140.49% | -883.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 607.64% | -75.02% | -95.39% | 849.62% | -99.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 607.64% | -75.02% | -95.39% | 849.62% | -99.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.87% | 1,300.46% | -133.65% | 114.44% | -245.47% |